Cargando…
Aptamedicine: a new treatment modality in personalized cancer therapy
Aptamers ( Aps ) are short single-strand nucleic acids exhibiting unique 3D structure which facilitate their targeting potential against various cancer molecular markers ( CMMs ). Such features of Aps not only make them as suitable homing agents in targeted drug delivery systems (DDSs) but also cand...
Autores principales: | Vandghanooni, Somayeh, Eskandani, Morteza, Barar, Jaleh, Omidi, Yadollah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637218/ https://www.ncbi.nlm.nih.gov/pubmed/31334037 http://dx.doi.org/10.15171/bi.2019.09 |
Ejemplares similares
-
Personalized cell-mediated immunotherapy and vaccination: combating detrimental uprisings of malignancies
por: Barar, Jaleh, et al.
Publicado: (2015) -
Molecular machineries of pH dysregulation in tumor microenvironment: potential targets for cancer therapy
por: Asgharzadeh, Mohammad Reza, et al.
Publicado: (2017) -
Surface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer
por: Barar, Jaleh, et al.
Publicado: (2014) -
Combating atherosclerosis with targeted nanomedicines: recent advances and future prospective
por: Nakhlband, Ailar, et al.
Publicado: (2018) -
Atherosclerosis preventive effects of marrubiin against (TNF-α)-induced oxidative stress and apoptosis
por: Nakhlband, Ailar, et al.
Publicado: (2023)